Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09GZH
|
||||
| Former ID |
DNC008556
|
||||
| Drug Name |
(R)-ONDANSETRON
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529281] | ||
| Formula |
C18H19N3O
|
||||
| Canonical SMILES |
CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
|
||||
| InChI |
1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3/t13-/m1/s1
|
||||
| InChIKey |
FELGMEQIXOGIFQ-CYBMUJFWSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [529281] | |
| PathWhiz Pathway | Muscle/Heart Contraction | ||||
| Reactome | Voltage gated Potassium channels | ||||
| References | |||||